|
ALKBH5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.46079994953897E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.35449487368578E-11 |
| Normal-vs-Stage2 |
2.721400E-01 |
| Normal-vs-Stage3 |
2.418600E-04 |
| Normal-vs-Stage4 |
1.894220E-02 |
| Stage1-vs-Stage2 |
8.442500E-03 |
| Stage1-vs-Stage3 |
7.821700E-02 |
| Stage1-vs-Stage4 |
1.533510E-02 |
| Stage2-vs-Stage3 |
1.962630E-01 |
| Stage2-vs-Stage4 |
5.736000E-01 |
| Stage3-vs-Stage4 |
4.000800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49959999973248E-08 |
| Normal-vs-AfricanAmerican |
2.074300E-02 |
| Normal-vs-Asian |
1.60175999999179E-05 |
| Caucasian-vs-AfricanAmerican |
3.491200E-01 |
| Caucasian-vs-Asian |
1.783550E-01 |
| AfricanAmerican-vs-Asian |
6.363900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.433400E-04 |
| Normal-vs-Female |
4.44089209850063E-13 |
| Male-vs-Female |
3.58229999997128E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.817000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.53190000018455E-07 |
| Normal-vs-Age(61-80Yrs) |
3.13969999998776E-07 |
| Normal-vs-Age(81-100Yrs) |
9.140300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.376370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.610040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.536800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.698000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.994200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.533400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.981110E-03 |
| Normal-vs-Grade 2 |
2.33060015730757E-10 |
| Normal-vs-Grade 3 |
2.370500E-04 |
| Normal-vs-Grade 4 |
1.138190E-02 |
| Grade 1-vs-Grade 2 |
7.058200E-02 |
| Grade 1-vs-Grade 3 |
4.836300E-03 |
| Grade 1-vs-Grade 4 |
4.260300E-03 |
| Grade 2-vs-Grade 3 |
8.416200E-03 |
| Grade 2-vs-Grade 4 |
3.191900E-02 |
| Grade 3-vs-Grade 4 |
8.110400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
8.477600E-02 |
| ccA subtype-vs-ccB subtype |
1.81140002997182E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.12839999996972E-06 |
| Normal-vs-N1 |
6.367600E-02 |
| N0-vs-N1 |
9.047000E-01 |
|
|
